0001209191-23-033191.txt : 20230531
0001209191-23-033191.hdr.sgml : 20230531
20230531192618
ACCESSION NUMBER: 0001209191-23-033191
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230526
FILED AS OF DATE: 20230531
DATE AS OF CHANGE: 20230531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenman William Mariner
CENTRAL INDEX KEY: 0001377258
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 23982643
MAIL ADDRESS:
STREET 1: C/O CERUS CORPORATION
STREET 2: 2411 STANWELL DRIVE
CITY: CONCORD
STATE: CA
ZIP: 94520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHINOOK THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH, SUITE 900
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-485-7051
MAIL ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH, SUITE 900
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH, INC.
DATE OF NAME CHANGE: 20111107
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-26
0
0001435049
CHINOOK THERAPEUTICS, INC.
KDNY
0001377258
Greenman William Mariner
C/O CHINOOK THERAPEUTICS, INC.
400 FAIRVIEW AVE. NO., 9TH FLOOR
SEATTLE
WA
98109
1
0
0
0
0
Common Stock
2023-05-26
4
M
0
3300
A
24798
D
Common Stock
2023-05-30
4
S
0
1155
23.30
D
23643
D
Restricted Stock Units
2023-05-26
4
M
0
3300
0.00
D
Common Stock
3300
0
D
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-l trading plan previously adopted by the Reporting Person and represent shares by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.
Each RSU represents a contingent right to receive one share of Issuer's common stock.
100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date.
/s/ Kirk Schumacher, Attorney-in-Fact
2023-05-31